Peri-ictal pseudoprogression in patients with brain tumor

Neuro-Oncology

Volumn 13, Issue 7, 2011, Pages 775-782

  Rheims, Sylvain ^a   Ricard, Damien ^d   Bent, Martin Van Den ⁱ   Taillandier, Luc ^f   Véronique, Bourg ^g   Désestret, Virginie ^a   Cartalat Carel, Stéphanie ^a,c   Hermier, Marc ^b   Monjour, Annick ^h   Delattre, Jean Yves ^e   Sanson, Marc ^e   Honnorat, Jérôme ^a,c   Ducray, François ^a,c  

^a CNRS   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c LYON NEUROSCIENCE RESEARCH CENTER   (France)

^d Service de Neurologie   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g PASTEUR HOSPITAL   (France)

^h Pasteur Hospital   (France)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brain tumor; Epilepsy; Glioma; Pseudoprogression; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PERI ICTAL PSEUDOPROGRESSION; SEIZURE; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; SURVIVAL RATE; SURVIVORS; TREATMENT OUTCOME;

EID: 80052719081     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor082     Document Type: Article

References (25)

1. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9:453-461. (Pubitemid 351597795)
2. Brandes AA, Franceschi E, Tosoni A, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008;26:2192-197.
3. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28: 1963-1972.
4. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY. CNS complications of radiotherapy and chemotherapy. Lancet. 2009;374:1639-1651.
5. Ruda R, Trevisan E, Soffietti R. Epilepsy and brain tumors. Curr Opin Oncol. 2010;22:611-620.
6. Chaichana KL, Parker SL, Olivi A, Quinones-Hinojosa A. Long-termseizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas: clinical article. J Neurosurg. 2009;111:282-292.
7. Hwang SL, Lin CL, Lee KS, et al. Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir (Wien). 2004;146:589-594: discussion 594. (Pubitemid 38788795)
8. Finn MA, Blumenthal DT, Salzman KL, Jensen RL. Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol. 2007;67:246-250; discussion 250. (Pubitemid 46274888)
9. Hattingen E, Franz K, Pilatus U, Weidauer S, Lanfermann H. Postictal spectroscopy and imaging findings mimicking brain tumor recurrence. J Magn Reson Imaging. 2006;24:226-230.
10. Hormigo A, Liberato B, Lis E, DeAngelis LM. Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities. Arch Neurol. 2004;61:362-365. (Pubitemid 38327353)
11. Quan D, Hackney DB, Pruitt AA, Lenkinski RE, Cecil KM. Transient MRI enhancement in a patient with seizures and previously resected glioma: use of MRS. Neurology. 1999;53:211-213. (Pubitemid 29329674)
12. Laigle F, Martin-Duverneuil N, Carpentier A, Hoang-Xuan K, Delattre JY. Seizure-related contrast enhancement of a ganglioglioma. Neurology. 2002;58:1538. (Pubitemid 34552964)
13. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. MRI abnormalities associated with partial status epilepticus. Neurology. 1999;52:1021-1027. (Pubitemid 29161614)
14. Szabo K, Poepel A, Pohlmann-Eden B, et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain. 2005;128:1369-1376. (Pubitemid 40826190)
15. Kim JA, Chung JI, Yoon PH, et al. Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging. AJNR Am J Neuroradiol. 2001;22:1149-1160.
16. Briellmann RS, Wellard RM, Jackson GD. Seizure-associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia. 2005;46:760-766. (Pubitemid 40628674)
17. Cole AJ. Status epilepticus and periictal imaging. Epilepsia. 2004;45(Suppl 4):72-77. (Pubitemid 39062809)
18. Goyal MK, Sinha S, Ravishankar S, Shivshankar JJ. Peri-ictal signal changes in seven patients with status epilepticus: interesting MRI observations. Neuroradiology. 2009;51:151-161.
19. Raghavendra S, Ashalatha R, Krishnamoorthy T, Kesavadas C, Thomas SV, Radhakrishnan K. Reversible periictal MRI abnormalities: clinical correlates and long-term outcome in 12 patients. Epilepsy Res. 2007;73:129-136. (Pubitemid 46084895)
20. Partap S, Walker M, Longstreth WT, Jr, Spence AM. Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology. 2006;66:1105-1107. (Pubitemid 44044803)
21. Murthy SN, Cohen ME. Pseudomigraine with prolonged aphasia in a child with cranial irradiation for medulloblastoma. J Child Neurol. 2002;17:134-138.] (Pubitemid 34498443)
22. Bartleson JD, Krecke KN, O'Neill BP, Brown PD. Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro Oncol. 2003;5:121-127. (Pubitemid 36416841)
23. Black DF, Bartleson JD, Bell ML, Lachance DH. SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia. 2006;26: 1137-1142. (Pubitemid 44199406)
24. Shuper A, Packer RJ, Vezina LG, Nicholson HS, Lafond D. 'Complicated migraine-like episodes' in children following cranial irradiation and chemotherapy. Neurology. 1995;45:1837-1840. (Pubitemid 27122954)
25. Kerklaan JP, Lycklama A, Nijeholt GJ, et al. SMART syndrome: a late reversible complication after radiation therapy for brain tumors. J Neurol. 2011;258(6):1098-1104.